We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




T Cell Training Enhances Immune System Diversity

By Biotechdaily staff writers
Posted on 19 Dec 2002
A recent study described the role of the major histocompatability complex (MHC) system in the training and activation of immune T cells. More...
The study was published in the November 29, 2002, issue of Science.

Investigators from the Oregon Health and Science University (Beaverton, USA) used mice infected with herpes simplex virus to evaluate the quality of the T cell response against the virus. They concentrated on molecules of the major histocompatability complex (MHC) system exposed on the surface of infected cells and alert T cells.

"The MHC molecules have two roles. First, they act like the traffic cops in the body. They look for invaders and, once they find them, they call in T cells to defeat a pathogen,” explained senior author Dr. Janko Nikolich-Zugich, a senior scientist at the Oregon Health and Science University Vaccine and Gene Therapy Institute. "But, just as importantly, they also ‘train' T cells when the pathogen is not around. They do this by selecting and expanding only those T cells that can be appropriately directed to find and destroy a pathogen when it attacks.”

By providing ‘training' to a wide, diverse set of T cells, some MHC molecules can ensure that the pathogen will be met by the very best T cells, able to kill the pathogen promptly at the beginning of infection. The more diverse set of T cells an animal has, the better chance the cells have of detecting a pathogen early and successfully fighting it off. The fact that as people age their T cell diversity drops helps explain why seniors are more susceptible to the flu and other diseases than the rest of the population

"This research is of particular interest to populations that are highly vulnerable to disease, such as the aging population,” said Dr. Nikolich-Zugich. "We hope that years down the road, this research finding will help us boost the immune systems of the elderly.”



Related Links:
Oregon Health and Science University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.